TELESIS BIO INC (TBIO) Stock Price & Overview
NASDAQ:TBIO • US1920032000
Current stock price
The current stock price of TBIO is 3.23 USD. Today TBIO is down by -19.05%. In the past month the price decreased by -3.87%. In the past year, price decreased by -82.75%.
TBIO Key Statistics
- Market Cap
- 5.717M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -23.94
- Dividend Yield
- N/A
TBIO Stock Performance
TBIO Stock Chart
TBIO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TBIO. When comparing the yearly performance of all stocks, TBIO is a bad performer in the overall market: 94.93% of all stocks are doing better.
TBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TBIO. TBIO may be in some trouble as it scores bad on both profitability and health.
TBIO Earnings
On August 7, 2024 TBIO reported an EPS of -3.83 and a revenue of 1.57M. The company beat EPS expectations (42.93% surprise) and missed revenue expectations (-23.04% surprise).
TBIO Forecast & Estimates
7 analysts have analysed TBIO and the average price target is 4.08 USD. This implies a price increase of 26.32% is expected in the next year compared to the current price of 3.23.
For the next year, analysts expect an EPS growth of -122.26% and a revenue growth -66.55% for TBIO
TBIO Groups
Sector & Classification
TBIO Financial Highlights
Over the last trailing twelve months TBIO reported a non-GAAP Earnings per Share(EPS) of -23.94. The EPS decreased by -1673.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -98.37% | ||
| ROE | -521.49% | ||
| Debt/Equity | 0.54 |
TBIO Ownership
TBIO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.38 | 175.844B | ||
| DHR | DANAHER CORP | 21.6 | 128.36B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 127.48 | 41.316B | ||
| A | AGILENT TECHNOLOGIES INC | 16.76 | 31.154B | ||
| WAT | WATERS CORP | 20.18 | 28.367B | ||
| IQV | IQVIA HOLDINGS INC | 13.02 | 27.506B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.52 | 25.047B | ||
| ILMN | ILLUMINA INC | 23.17 | 17.992B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.31 | 17.541B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.29 | 12.805B | ||
| RVTY | REVVITY INC | 15.3 | 9.38B | ||
| TECH | BIO-TECHNE CORP | 23.28 | 7.971B | ||
| CRL | CHARLES RIVER LABORATORIES | 14.41 | 7.835B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TBIO
Company Profile
Telesis Bio Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2021-06-18. Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The firm provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
Company Info
IPO: 2021-06-18
TELESIS BIO INC
10431 Wateridge Circle, Suite 150
San Diego CALIFORNIA 02421 US
CEO: Ronald C. Renaud Jr.
Employees: 137
Phone: 18582284115
TELESIS BIO INC / TBIO FAQ
Can you describe the business of TELESIS BIO INC?
Telesis Bio Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 137 full-time employees. The company went IPO on 2021-06-18. Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The firm provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
What is the stock price of TELESIS BIO INC today?
The current stock price of TBIO is 3.23 USD. The price decreased by -19.05% in the last trading session.
What is the dividend status of TELESIS BIO INC?
TBIO does not pay a dividend.
What is the ChartMill technical and fundamental rating of TBIO stock?
TBIO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of TBIO stock?
TELESIS BIO INC (TBIO) operates in the Health Care sector and the Life Sciences Tools & Services industry.
What is the expected growth for TBIO stock?
The Revenue of TELESIS BIO INC (TBIO) is expected to decline by -66.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of TBIO stock?
TELESIS BIO INC (TBIO) has a market capitalization of 5.72M USD. This makes TBIO a Nano Cap stock.